MDM2 and neuroblastoma: To initially assess the p53-dependent response we used the MDM2 inhibitor Nutlin-3a to stabilize p53 in a panel of primary (p202, p218, and H) and established neuroblastoma lines and tested its ability to induce apoptosis in neuroblastoma cells compared to other solid tumors.